利伐沙班用于近期接受外周动脉血运重建术且有肾功能损害的患者：VOYAGER PAD试验 - Suppr

Rivaroxaban in Patients With Recent Peripheral Artery Revascularization and Renal Impairment: The VOYAGER PAD Trial.

作者信息

Hsia Judith, Szarek Michael, Anand Sonia, Patel Manesh R, Debus Sebastian, Berkowitz Scott D, Muehlhofer Eva, Haskell Lloyd P, Bauersachs Rupert M, Bonaca Marc P

出版信息

J Am Coll Cardiol. 2021 Aug 17;78(7):757-759. doi: 10.1016/j.jacc.2021.06.021.

DOI:10.1016/j.jacc.2021.06.021

PMID:34384556

Abstract

摘要

相似文献

Rivaroxaban in Patients With Recent Peripheral Artery Revascularization and Renal Impairment: The VOYAGER PAD Trial.

J Am Coll Cardiol. 2021 Aug 17;78(7):757-759. doi: 10.1016/j.jacc.2021.06.021.

Total Ischemic Event Reduction With Rivaroxaban After Peripheral Arterial Revascularization in the VOYAGER PAD Trial.

J Am Coll Cardiol. 2021 Jul 27;78(4):317-326. doi: 10.1016/j.jacc.2021.05.003. Epub 2021 May 16.

VOYAGER PAD contributes to medical therapy for peripheral artery disease.

J Vasc Surg. 2020 Dec;72(6):1843-1844. doi: 10.1016/j.jvs.2020.06.101.

The Voyager PAD Trial - New Path for Post-revascularisation PAD Patients.

Eur J Vasc Endovasc Surg. 2020 May;59(5):699-700. doi: 10.1016/j.ejvs.2020.03.041. Epub 2020 Apr 16.

Editor's Choice - Revascularisation for Peripheral Artery Disease in France: Implications for the Implementation of VOYAGER-PAD.

Eur J Vasc Endovasc Surg. 2024 Jun;67(6):969-978. doi: 10.1016/j.ejvs.2024.01.091. Epub 2024 Feb 3.

Editor's Choice - External Applicability of the COMPASS and VOYAGER-PAD Trials on Patients with Symptomatic Lower Extremity Artery Disease in France: The COPART Registry.

Eur J Vasc Endovasc Surg. 2021 Sep;62(3):439-449. doi: 10.1016/j.ejvs.2021.05.028. Epub 2021 Jul 28.

Rationale and design for the Vascular Outcomes study of ASA along with rivaroxaban in endovascular or surgical limb revascularization for peripheral artery disease (VOYAGER PAD).

Am Heart J. 2018 May;199:83-91. doi: 10.1016/j.ahj.2018.01.011. Epub 2018 Feb 3.

Low-Dose Rivaroxaban Plus Aspirin in Patients With Peripheral Artery Disease Undergoing Lower Extremity Revascularization With and Without Concomitant Coronary Artery Disease: Insights From VOYAGER PAD.

Circulation. 2024 May 7;149(19):1536-1539. doi: 10.1161/CIRCULATIONAHA.124.068080. Epub 2024 May 6.

New treatments for peripheral artery disease.

Cleve Clin J Med. 2020 May;87(5 suppl 1):21-25. doi: 10.3949/ccjm.87.s1.03.

Rivaroxaban in Peripheral Artery Disease after Revascularization.

N Engl J Med. 2020 May 21;382(21):1994-2004. doi: 10.1056/NEJMoa2000052. Epub 2020 Mar 28.

引用本文的文献

Ten tips to manage oral anticoagulation in hemodialysis patients with atrial fibrillation.

Clin Kidney J. 2024 Oct 4;17(10):sfae270. doi: 10.1093/ckj/sfae270. eCollection 2024 Oct.

Current Status and Principles for the Treatment and Prevention of Diabetic Foot Ulcers in the Cardiovascular Patient Population: A Scientific Statement From the American Heart Association.

Circulation. 2024 Jan 23;149(4):e232-e253. doi: 10.1161/CIR.0000000000001192. Epub 2023 Dec 14.

Sex Differences in Peripheral Artery Disease.

Circ Res. 2022 Feb 18;130(4):496-511. doi: 10.1161/CIRCRESAHA.121.320702. Epub 2022 Feb 17.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Rivaroxaban in Patients With Recent Peripheral Artery Revascularization and Renal Impairment: The VOYAGER PAD Trial.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献